#h2 2017

Heterozygous familial hypercholesterolemia (heFH) – Pipeline Review, H2 2017

Heterozygous familial hypercholesterolemia (heFH) – Pipeline Review, H2 2017 Access Full Report: https://www.reportsandmarkets.com/reports/heterozygous-familial-hypercholesterolemia-hefh-pipeline-review-h2-2017-1740474 Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Heterozygous familial hypercholesterolemia (heFH) – Pipeline Review, H2 2017, provides an…

Lung Transplant Rejection – Pipeline Review, H2 2017

Lung Transplant Rejection – Pipeline Review, H2 2017 Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Lung Transplant Rejection – Pipeline Review, H2 2017, provides an overview of the Lung Transplant Rejection (Immunology) pipeline landscape. Access Full Report: https://www.reportsandmarkets.com/reports/lung-transplant-rejection-pipeline-review-h2-2017-1731164…

Anaphylaxis – Pipeline Review, H2 2017

Anaphylaxis – Pipeline Review, H2 2017 Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis – Pipeline Review, H2 2017, provides an overview of the Anaphylaxis (Immunology) pipeline landscape. Access Full Report: https://www.reportsandmarkets.com/reports/anaphylaxis-pipeline-review-h2-2017-1731163 Anaphylaxis is a severe, potentially life-threatening…

Pemphigus Vulgaris – Pipeline Review, H2 2017

Pemphigus Vulgaris – Pipeline Review, H2 2017 Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris – Pipeline Review, H2 2017, provides an overview of the Pemphigus Vulgaris (Immunology) pipeline landscape. Access Full Report: https://www.reportsandmarkets.com/reports/pemphigus-vulgaris-pipeline-review-h2-2017-1731162 Pemphigus vulgaris is a rare…